Levi & Korsinsky, LLP announces that a DECN class action lawsuit has been filed on behalf of investors who purchased Decision Diagnostics Corp. (DECN) securities between March 3, 2020 and December 17, 2020. For more on the DECN Lawsuit please contact us today.  

According to the Decision Diagnostics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Decision Diagnostics had not developed any viable COVID-19 test, much less a test that could detect COVID-19 in less than one minute; (ii) the Company could not meet the FDA’s EUA testing requirements for its purported COVID-19 test; (iii) accordingly, Defendants had misrepresented the timeline within which it could realistically bring its COVID-19 test to market; (iv) all the foregoing subjected Defendants to an increased risk of regulatory oversight and enforcement; and (v) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE DECN CLASS ACTION LAWSUIT, CLICK HERE 

If you suffered a loss in Decision Diagnostics you have until March 16, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com